ArticleCancer immunology, immunotherapy : CII2013

Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.

Guohong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.